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Abstract: Background and objectives: Cleft lip palate takes the second place among all anomalies. The
complex appearance of cytokines and proliferation markers has still not been clarified despite their
possible crucial role in cleft tissue. Therefore, the aim of work was the detection of appearance of
pro- and anti-inflammatory cytokines and proliferation marker Ki67, and their inter-correlations in
cleft affected lip (CAL). Materials and Methods: The lip material was obtained from 16 children aged
before primary dentition during plastic surgery. Control was obtained from 7 non-CAL oral tissue.
Tissues were stained for IL-1, IL-4, IL-6, IL-8, IL-10 and Ki67 immunohistochemically. Non-parametric
statistic, Mann–Whitney and Spearman’s coefficient were used. Results: All cytokines positive
cells were observed more into the epithelium. Statistically significant difference was seen between
epithelial IL-1, IL-10, IL-8 and Ki67 positive cells and IL-10-, IL-4-containing connective tissue cells
in comparison to the control. Strong positive correlation was detected in CAL epithelium between
IL-10 and IL-8, IL-10 and IL-4, IL-10 and IL-1, IL-1 and IL-8, IL-1 and IL-4, IL-4 and IL-8, IL-8 and
Ki67, IL-10 and Ki67, but moderate—in connective tissue between IL-1 and IL-10, IL-1 and IL-4.
Conclusions: The CAL epithelium is the main source for the interleukins. Rich similar expression of
IL-1 and IL-10 suggests the balance between pro-and anti-inflammatory tissue response on basis
of dysregulated tissue homeostasis (increase of IL-8). The correlations between the different ILs-1,
-4, -8, -10 in CAL epithelium seem to indicate the self-protection compensatory mechanism for
intensification of local inflammatory-immune response without involvement of IL-6. The correlations
between Ki67 and cytokines indicate the involvement of IL-8 and IL-10 in stimulation of cellular
proliferation. IL-4 and IL-10 expression from CAL connective tissue simultaneously to IL-1, IL-4
and IL-10 inter-correlations there suggests the intensification of local immune response regulated
probably by main pro-inflammatory cytokine—IL-1.
Keywords: cytokines; proliferation marker; lip; children; cleft
1. Introduction
Cleft lip palate (CLP) is one of the most common congenital malformations with estimated
incidence at 1 in 600–1000 births worldwide [1,2]. From all anomalies, it occupies the stable second
position with slight variations regarding the race, geographic region, environmental and some other
probably unknown factors of influence for CLP development. Significance of this disorder is mentioned
even in the Global Burden of Disease (GBD) project, which provides longitudinal analysis of the global
burden of diseases by measuring the all-cause mortality, years of life lost, the years of life lived with
disability, and disability-adjusted life years [3].
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Morphopathogenesis of CLP is not completely understood and it is the reason for the ongoing
interest of scientists in different developmental and postnatal aspects of clefts. Inflammation and
inflammatory cytokines belong to one such aspect. Therefore, children with CLP are known to show
greater oral tissue inflammation despite the same persistence of microorganisms than the children
without cleft [4]. Relevant studies have indicated the inflammation of tissue as one of the main tissue
modulators in the cleft affected regions due to the dysregulated chronic character of inflammation that
disturbs the common tissue remodelation in normal wound healing [5]. However, there has been only
very limited research done regarding the detection of main indicators of inflammatory process—pro-
and anti-inflammatory cytokines into the cleft affected tissue. Some interleukins (ILs) like IL-7 and
IL-10 are described as the main immune response regulators in the hard tissue of cleft patients [6], but
during the research on the human fibroblasts obtained from CLP the inhibitory effect of IL-6 on the
collagen and glycosaminoglycan level was detected [7].
Despite the still scarce studies on the whole cytokine class in CLP affected tissue, interest in the
significance of some interleukins: IL-1, -4, -6, -7, -8, and -10 in common body tissue aspect and especially
in oral tissue has increased in the last decade. Generally, orofacial tissue develops from craniofacial
mesenchyme interacting with immune cells. In return, immune cells attenuate their function by
secreting inflammatory cytokines such as interleukin IL-1, mainly IL-1β [8]. Epidermal keratinocytes
are also a rich source of ILs, mainly IL-1α, which is released at the time of tissue damage [9]. IL-1α is
active as a zymogen and, upon secretion from epidermal keratinocytes, can play key roles in the early
inflammatory phase of the wound-healing response [10]. In addition, IL-1α mediates the reciprocal
crosstalk between cells within the epidermis and dermis that promotes the secretion of stem cell
proliferation factors [11,12]. IL-1 can also be considered among the most common biomarkers that give
precise results and can be used as an indicator of periodontal disease progression [13]. Commonly,
IL-1 induces expression of macrophage inflammatory protein-1α in polymorphonuclear leukocytes
and human gingival epithelial cells and its elevated levels have been reported in inflammatory bone
diseases including periodontitis [14].
Interleukin-4 (IL-4) is a pleiotropic cytokine secreted by activated T lymphocytes, mast cells,
eosinophils, and basophils. It is the key player in humoral and adaptive immunity by regulating
the function of immune cells, such as lymphocytes and macrophages [15,16]. IL-4 is a cytokine that
monitors the immuno-inflammatory response associated with severe inflammation [17]. The presence
of IL-4-producing cells is significantly higher in periodontal lesions compared to gingival tissues [18].
IL-4 is a common finding in human skin [19]. Finally, also a pro-inflammatory effect of IL-4 in vascular
tissues, especially in endothelial cells has been described [20].
IL-6 is mainly regarded as a pro-inflammatory cytokine; meanwhile also anti-inflammatory
activities are noted [21]. Pro-inflammatory cytokines are multipotent, critical for cellular homeostasis
and play a vital regulatory role in the inflammation process. The overproduction of cytokines can be the
root for harmful inflammatory reactions. The upregulation of pro-inflammatory cytokines contributes
to enhanced monocyte adhesiveness and infiltration into the skin during the pathogenesis of various
inflammatory skin diseases, such as atopic dermatitis [22]. Various cell types including lymphocytes,
fibroblasts, endothelial cells and macrophages produce and secrete IL-6 [23]. Keratinocytes also
produce a variety of cytokines including IL-6 and tumor necrosis factor-alpha (TNFα). The disparity
in cytokine levels can promote the onset of inflammatory diseases [24]. Additionally, IL-6 induces
a variety of responses from many cell types. Primary effects include B-cell differentiation and the
stimulation of acute phase proteins [25].
IL-8 is a major neutrophil chemotactic factor involved in the acute inflammation [26]. Generally, IL-8
deploys its function in conjunction with other cytokines and chemokines resulting in chemoattraction
of leukocytes to the inflammatory sites, recruitment and activation of neutrophils to phagocytosis and
bacterial clearance. Furthermore, IL-8 possesses chemoattractant activity on basophils and T cells;
additionally, it has a potent pro-angiogenic action. Therefore, IL-8 is crucially involved in several
inflammatory diseases [27,28]. Interestingly, inflammation in the oral mucosa might lead to changes in
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the DNA methylation status of the IL-8 gene in epithelial oral cells [29]. Together with the idea that
IL-8 is a significant player in the oral tissue common homeostasis, it is also supposed to explore a
notable role in pathological conditions of the tissues [30].
IL-10 is essential for regulating macrophage and neutrophil infiltration as well as cytokine
production during the inflammatory response of cutaneous wound healing [31]. IL-10 is an
immunoregulatory cytokine with potent anti-inflammatory properties. It can repress the synthesis of
major inflammatory cytokines including TNFα, IL-1, IL-6 and IL-12 as well as chemokines [32]. IL-10
may play a remarkable role in wound healing due to the regulation of pro-inflammatory cytokines.
Overexpression of IL-10 in adult murine wounds reduces collagen deposition and improves wound
healing [33]. Finally, IL-10 is thought to be involved in the regulation of type I collagen synthesis and
degradation [34]. As mentioned earlier, all the above-mentioned ILs may modulate the CLP affected
tissues and they have been researched only solitarily in the case of this anomaly.
The idea about the impact of high craniofacial tissue proliferation potential indicates the interest
in the Ki67 protein and its possible connection to the cytokine-mediated tissue remodelation. The
Ki67 protein is well characterized on the molecular level. It is associated with all phases of cell cycle
except G0, Ki67 is located in the cortex of the nucleus and is known to be present in all proliferating
cells. Therefore, it has been used as a surrogate marker to rate the proliferation index particularly in
the diagnosis for carcinogenesis [35]. Interestingly, there are indications regarding slightly different
phenotype of oral and lip epithelium where Ki67 also may play a significant role [36]. The common
functional significance of Ki67 still remains unclear both in healthy and in cleft affected tissue condition.
There are indications, however, that Ki67 protein expression is an absolute requirement for progression
through the cell-division cycle and it means that it is absolutely necessary for the proliferation. Despite
the fact that nothing is known about this protein and different ILs correlations [37] especially in case
of clefts.
Based on the importance of cytokine functions in morphopathogenesis of clefts, absence of their
correlative search with proliferation markers in CLP affected tissue, the aim of our work was the
research of appearance and distribution of pro- and anti-inflammatory cytokines, proliferation marker
Ki67 and the detection of inter-correlations between these factors in cleft affected lip (CAL) of children.
2. Materials and Methods
2.1. Materials Characteristics of Subjects
This study was independently reviewed and approved by the local Ethical Committee of the Riga
Stradins University (22.05.2003; 17.01.2013; 5/25.06.2018), Project Nr.5-1/106/2019 of 12.04.2019) as well
as a written informed consent was obtained from all parents after the nature of the study had been
fully explained. All of the patients and parents gave their informed consent to participate in the study.
Tissues were retrieved from the Cleft Lip and Palate Centre of the Institute of Stomatology, but the
study was conducted at the Department of Morphology of the Riga Stradins University, Latvia. The lip
material from the defect place was obtained from 16 children (10 boys, 6 girls) aged before primary
dentition (3 months to 1.6 years; commonly, the primary dentition age continues until a child turns
6 years old) during plastic surgery of bilateral (2) and unilateral clefts (14). Seven control samples were
obtained from lip mucosal part during upper labial frenectomy due to the correction of low attached
upper lip frenulum, but the tissues were not associated with CLP, inflammation or any other pathology.
Age of control children (4 boys and 3 girls) extended from 5 years to 6 years and 6 months (from all
controls, the age of the two oldest children slightly exceeded the primary dentition age, but they still
were included into the control group due to the unique character of the tissue as border cases).
2.2. Immunohistochemical Analysis
Tissues were fixed for a day in a mixture of 2% formaldehyde and 0.2% picric acid in 0.1 M
phosphate buffer (pH 7.2). Afterwards they were rinsed in Tyrode buffer (content: NaCl, KCl,
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CaCl2·2H2O, MgCl2·6H2O, NaHCO3, NaH2PO4·H2O, glucose) containing 10% saccharose for 12 h and
then embedded into the paraffin. Three micrometres thin sections were cut, which were then stained
with hematoxylin and eosin for routine morphological evaluation. Biotin-Streptavidin biochemical
method was used for immunohistochemistry (IMH) to detect: IL-1 (orb308737, working dilution 1:100,
Biorbyt Limited, Cambridge, UK), IL-4 (orb10908, working dilution 1:100, Biorbyt Limited, Cambridge,
UK), IL-6 (sc-130326, working dilution 1:100, Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA), IL-8
(orb 39299, working dilution 1:100, Biorbyt Limited, Cambridge, UK), IL-10 (250713, working dilution
1:100, BioSite, Täby, Sweden), Ki67 (1508202A, working dilution 1:100, Sigma-Aldrich, St. Louis, MO,
USA), and anti-macrophage inflammatory protein 1 beta (MIP-1ß, ab9675, working dilution 1:100,
Abcam, Cambridge, UK).
The slides were analysed by light microscopy using non-parametric evaluation. The results were
evaluated by grading the appearance of positively stained cells in the visual field [38]. Structures in
the visual field were labelled as follows: 0—no positive structures, 0/+—occasional positive structures,
+—few positive structures, +/++—few to moderate number of positive structures, ++—moderate
number of positive structures, ++/+++—moderate to numerous positive structures, +++—numerous
positive structures, +++/++++—numerous to abundant structures, ++++—abundance of positive
structures in the visual field.
For visual illustration, Leica DC 300F digital camera and image processing and analysis software
Image Pro Plus (Media Cybernetics, Inc., Rockville, MD, USA) were used.
2.3. Statistical Analysis
The data processing was performed with SPSS software, version 22.0 (IBM Company, Chicago, IL,
USA). We used Spearman’s rank correlation coefficient, where r = 0–0.2 was assumed as a very weak
correlation, r = 0.2–0.4—a weak correlation, r = 0.4–0.6—a moderate correlation, r = 0.6–0.8—a strong
correlation and r = 0.8–1.0—a very strong correlation. To analyse control group versus patient data, we
used Mann–Whitney U test. The level of significance for all tests was chosen as 5% (p-value < 0.05).
3. Results
The CAL material contained stratified squamous epithelium and submucosal connective
tissue in all cases. Routine staining discovered patchy vacuolization of the lip epithelial cells
(keratosis seborrhoea), patchy proliferation of the basal cells and patchy subepithelial inflammation
with appearance of the sclerosis in small arteries (Figure 1a,b). MIP-1ß marked appearance of
pro-inflammatory macrophages or directly beneath the basal membrane or diffusely distributed in
subepithelium (Figure 1c,d).
Proliferation marker Ki67 marked moderate number of epithelial cells in lip epithelium with five
cases when only occasional positive epitheliocytes were observed (Table 1, Figure 2a). No Ki67 positive
cells were seen in the control tissue (Figure 2b).
Positive cells of all cytokines were observed more in the epithelium. Moderate to numerous
IL-1-containing CAL epitheliocytes prevailed in comparison to few such cells in control (Table 1,
Figure 2c), while there was no difference between the numbers of factor positive connective tissue cells,
mainly fibroblasts and macrophages (Figure 2d) of patients and controls. IL-4 positive cells slightly
varied (from moderate to numerous) in patients’ epithelium, but generally did not differ from the
indices in control tissue. Interestingly, patients possessed moderate number of IL-4 immunoreactive
connective tissue cells, while controls demonstrated only few of them in the subepithelium (Table 1,
Figure 2e,f).
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Figure 1. (a–d) Micrographs of cleft lip affected lip in children. (a) Note patchy vacuolization of
the lip epithelium (keratosis seborrhoea) in a 3-month-old child. Hematoxylin and eosin, X 200;
(b) Visible proliferation of the basal epitheliocytes and subepithelial inflammation in a 3-month-old
child. Hematoxylin and eosin, X 250. (c) MIP-1ß immunoreactive macrophages are located strictly
beneath the basal membrane of 5-month-old child. MIP-1ß IMH, X 200; (d) Note diffuse distribution of
MIP-1ß immunoreactive macrophages in subepithelial connective tissue of 4-month-old child. MIP-1ß
IMH, X 200.
Table 1. Relative number of cytokines and proliferation marker Ki67 positive structures in the cleft
affected lip epithelium and subepithelial connective tissue.
Factors/
Subjects
Ki67 IL-1 IL-4 IL-6 IL-8 IL-10
E E CT E CT E CT E CT E CT
1. ++/+++ +/++ + +++ ++ +++ ++ ++/+++ +++ +++ +++
2. 0/+ +++ ++ +++ ++ ++++ ++ +++ +++ +++ +++
3. 0/+ + ++ ++ ++ +/++ 0 0 0 +/++ +
4. 0 0 +/++ + + 0 ++ ++ +/++ + +
5. ++/+++ ++ +++ + +++ ++ +++ 0 ++ ++ +++
6. ++ +++ ++ ++ +++ +++ +++ ++ ++ +++ ++
7. ++ +++ ++ +++ +++ +++ +++ +++ +++ +++ ++
8. ++/+++ +++ ++ +++ +++ +++ +++ +/++ ++ +++ ++
9. +++ +++ ++ +++ +++ +++ +++ 0 ++ +++ ++
10. ++/+++ ++++ ++ +++ +++ +++ +++ 0 + ++++ +++
11. 0/+ +/++ ++ + + +/++ ++ 0/+ ++/+++ ++ ++
12. ++ +++ ++ +++ + +++ +++ ++ ++ +++ ++
13. 0/+ ++ ++ 0 + +/++ ++ 0 + ++ ++
14. ++ +++ +++ +++ +++ ++/+++ +++ 0/+ +++ ++/++ +++
15. ++ ++ ++ ++ ++ ++ ++ +/++ +++ ++ ++
16. +/++ +++ ++ +++ ++ ++ +++ +/++ +++ ++ +/++
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Figure 2. (a–f). Immunohistochemical micrographs in cleft affected lip of children and in control 
subjects. (a) Note moderate number of basal and suprabasal Ki67 positive cells in epithelium of a 5-
month-old cleft affected child. Ki67 IMH, X 200; (b) The lip epithelium lacks Ki67 positive cells in 
control lip of a 5-year-old child. Ki67 IMH, X 200; (c) Note numerous number of IL-1-containing 
epithelial and connective tissue cells of 3-month-old cleft affected child. IL-1 IMH, X 200; (d) Moderate 
number of IL-1 positive connective tissue cells placed in the subepithelium of 6-year-old control child. 
IL-1 IMH, X 200; (e) Moderate number of IL-4 immunoreactive epitheliocytes and connective tissue 
cells in subepithelium of 4-month-old cleft affected child. IL-4 IMH, X200. (f) Note moderate number 
of IL-4 epithelial cells and only few weakly stained connective tissue cells of 6-year- old control 
subject. IL-4 IMH, X 200. 
Numerous IL-6-containing epithelial and connective tissue cells in patients notably exceeded the 
few to moderate number of factor positive cells in control locations (Table 1, Figure 3a,b). IL-8 positive 
epithelial cells varied in patients with mostly rare appearance, but demonstrated similar appearance 
of mainly moderate immunoreactive connective tissue cells in patients and controls (Table 1, Figure 
3c,d). Moderate to numerous IL-10 positive epithelial cells were detected in patients, while the 
controls demonstrated only few factor positive epitheliocytes. In addition, connective tissue of 
patients possessed notably more (++) IL-10-containing cells in comparison to the controls (+) (Table 
1, Figure 3e,f). 
Figure 2. (a–f) Immunohistoc emical micrographs in cleft affect d lip of children and in control subjects.
(a) Note moderate number of basal and suprabasal Ki67 positive cells in epithelium of a 5-month-old
cleft affected child. Ki67 IMH, X 200; (b) The lip epithelium lacks Ki67 positive cells in control lip
of a 5-year-old child. Ki67 IMH, X 200; (c) Note numerous number of IL-1-containing epithelial and
connective tissue cells of 3-month-old cleft affected child. IL-1 IMH, X 200; (d) Moderate number
of IL-1 positive connective tissue cells placed in the subepithelium of 6-year-old control child. IL-1
IMH, X 200; (e) Moderate number of IL-4 immunoreactive epitheliocytes and connective tissu cells in
subepithelium of 4-month-old cleft affected child. IL-4 IMH, X200. (f) Note moderate number of IL-4
epithelial cells and only few weakly stained connective tissue cells of 6-year- old control subject. IL-4
IMH, X 200.
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Numerous IL-6-containing epithelial and connective tissue cells in patients notably exceeded
the few to moderate number of factor positive cells in control locations (Table 1, Figure 3a,b). IL-8
positive epithelial cells varied in patients with mostly rare appearance, but demonstrated similar
appearance of mainly moderate immunoreactive connective tissue cells in patients and controls (Table 1,
Figure 3c,d). Moderate to numerous IL-10 positive epithelial cells were detected in patients, while
the controls demonstrated only few factor positive epitheliocytes. In addition, connective tissue of
patients possessed notably more (++) IL-10-containing cells in comparison to the controls (+) (Table 1,








Figure 3. (a–f). Immunohistochemical micrographs of cleft affected lip in children and in control 
subjects. (a) Note moderate number of IL-6 immunoreactive cells in connective tissue of 1-year-1-
month-old cleft affected child. IL-6 IMH, X 200; (b) Moderate number of IL-6 positive connective 
tissue cells in 6-year-old control lip. IL-6 IMH, X 200; (c) Note moderate number of IL-8 
immunoreactive cells located in the epithelium and connective tissue of 4-month-old cleft affected 
child. IL-8 IMH, X 250; (d) Note moderate number of positive for IL-8 connective tissue cells in 5-year-
old control subject. IL-8 IMH, X 200; (e) Note moderate number of IL-10 immunoreactive 
epitheliocytes and connective tissue cells in 3-month-old cleft affected child. IL-10 IMH, X200; (f) Five-
year-old control subject displaying only a few IL-10 positive connective tissue cells. IL-10 IMH, X 200. 
A statistically significant difference was seen between numbers of epithelial IL-1-, IL-8-, IL-10- 
and Ki67-containing cells as well as IL-10, IL-4 positive connective tissue cells in comparison to the 
control (Table 2). 
  
Figure 3. (a–f) Immunohistochemical microg aphs of cleft affected lip in children and in control subjects.
(a) Not moderate numb r of IL-6 immunoreactive cells in connective tissue of 1-year-1-month-old
cleft affected child. IL-6 IMH, X 200; (b) Moderate number of IL-6 positive connective tissue cells in
6-year-old control lip. IL-6 IMH, X 200; (c) Note moderate number of IL-8 immunoreactive cells located
in the epithelium and connective tissue of 4-month-old cleft affected child. IL-8 IMH, X 250; (d) Note
moderate number of positive for IL-8 connective tissue cells in 5-year-old control subject. IL-8 IMH,
X 200; (e) Note moderate number of IL-10 immunoreactive epitheliocytes and connective tissue cells in
3-month-old cleft affected child. IL-10 IMH, X200; (f) Five-year-old control subject displaying only a
few IL-10 positive connective tissue cells. IL-10 IMH, X 200.
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A statistically significant difference was seen between numbers of epithelial IL-1-, IL-8-, IL-10-
and Ki67-containing cells as well as IL-10, IL-4 positive connective tissue cells in comparison to the
control (Table 2).
Table 2. Mann–Whitney U test revealing statistically significant differences in factors of different
locations between the patients and controls.
Detected Factor Mann–Whitney U Z-Score p-Value
IL-1 in epithelium 14.5 2.06431 0.01394
IL-8 in epithelium 15.5 2.35907 0.01828
IL-10 in epithelium 20.5 2.33854 0.01928
Ki67 in epithelium 10.5 3.00669 0.00262
IL-4 in connective tissue 16 2.32221 0.02034
IL-10 in connective tissue 6 3.30736 0.00094
Abbreviations: Ki67—proliferation marker; IL-1—interleukin 1; IL-4—interleukin 4; IL-8—interleukin 8;
IL-10—interleukin 10.
A strong positive correlation was detected in CLP epithelium between IL-10 and IL-8, IL-10 and
IL-4, IL-10 and IL-1, IL-1 and IL-8, IL-1 and IL-4, IL-4 and IL-8, IL-8 and Ki67, IL-10 and Ki67, but a
moderate correlation was detected in connective tissue between IL-1 and IL-10, IL-1 and IL-4 (Table 3).
No correlations were found between factors in controls.
Table 3. Spearman’s rank correlation coefficient revealed correlations between the relative numbers of
different tissue factors in CLP affected epithelium and connective tissue.
Factor 1 Factor 2 R p-Value
Very strong positive correlation
IL-10 in epithelium IL-8 in epithelium 0.92791 0
Strong positive correlation
IL-10 in epithelium IL-4 in epithelium 0.77857 0.00038
IL-10 in epithelium IL-1 in epithelium 0.72389 0.00152
IL-1 in epithelium IL-8 in epithelium 0.77684 0.0004
IL-1 in epithelium IL-4 in epithelium 0.68943 0.00313
IL-4 in epithelium IL-8 in epithelium 0.72045 0.00164
Ki67 in epithelium IL-8 in epithelium 0.64175 0.00736
IL-10 in connective tissue IL-4 in connective tissue 0.65084 0.00632
Moderate positive correlation
Ki67 in epithelium IL-10 in epithelium 0.56539 0.02246
IL-1 in connective tissue IL-4 in connective tissue 0.55068 0.02707
IL-10 in connective tissue IL-1 in connective tissue 0.51299 0.04214
Abbreviations: Ki67—proliferation marker; IL-1—interleukin 1; IL-4—interleukin 4; IL-10—interleukin 10.
4. Discussion
The lip and oral epithelium generally separates the host from the environment and presents as
the first line of defense against pathogens, exogenous substances and mechanical stress [39]. From
all interleukins researched in our patients, the IL-1, IL-8 and IL-10 were the most expressed ones
presenting particularly in the epithelium simultaneously with proliferation marker Ki67. Therefore,
we suggest the specific expression/role of these cytokines being the dominant in the cleft affected
epithelial barrier, which remarkably stimulates the proliferation of cells. This is proved also by the
other scientists who have indicated the role of epithelium as a structure regulating the innate and
adaptive immune responses against foreign substances and microorganisms [40]. However, in the case
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of an oral bacterial infection, mainly the expression of IL-1, IL-6 and also TNFα has been demonstrated
to be the most prominent in gingival epithelium up to now [39].
Cleft affected lip tissue shows unequal regeneration as it is regularly affected by mechanical and
also bacterial influence, at least in untreated condition. Interestingly, IL-1 is the main pro-inflammatory
cytokine, but its expression has been regarded as necessary for healing; however, its importance has
also been implicated in delayed wound repair. All these effects take place in CAL. We can agree
to the point that there still is no direct evidence on IL-1 central role in the healing [41] and thus its
capacity is mainly associated with the persistence of the inflammation. Furthermore, the elevated
level of IL-1 supposedly modulates the tissue remodeling up to epithelial proliferation and cellular
apical migration, loss of cell attachment, and even destruction of hard tissue in ongoing cytokine
expression [42]. IL-8, on the other hand, is known to regulate oral tissue homeostasis [30] and its
increase seems to be based on bacterial/viral and mechanical dysregulation of epithelium integrity.
Additionally, elevation of cytokines such as IL-1 (as well as TNFα) can also essentially increase the
expression of this cytokine [43].
IL-10 was the third most common interleukin in the CAL epithelium in our patients. Initially
it was assumed that IL-10 is only produced by immune cells, further studies revealed that IL-10 is
produced by non-immune cells as well, including keratinocytes, epithelial cells and tumor cells for
instance [32]. As the patchy inflammation was detected in subepithelium in CAL, we speculate of
common compensatory inflammation-suppressing expression of IL-10 from epithelial and connective
tissue cells in long term persisting cleft raised inflammation circumstances. The main target cells
for IL-10 include monocytes and macrophages. IL-10 suppresses the release of pro-inflammatory
cytokines and therefore inhibits the secretion of TNF-α and IL-6. IL-10 also suppresses functions of
antigen presentation by blocking Major histocompatibility complex (MHC) class II expression and
co-stimulatory molecules such as CD80 and CD86, but exalts the phagocytosis of cells. Finally, IL-10
inhibits the release of pro-inflammatory mediators by neutrophils and the secretion of chemokines to
attract neutrophils, which is an equally important function at an acute inflammation stage [44].
We detected also strong and moderate correlations between the appearances of different
interleukins in the cleft affected epithelium that were not seen in the control. We suppose that
this interesting finding indicates the common self-protection compensatory mechanism in the CAL
epithelium, which serves as a balance between the regulatory tissue factors in seriously damaged tissue.
Interesting questions are raised due to the elevated Ki67 appearance, which clearly indicates the
presence of proliferating cells. We speculate on the triggered influence of some interleukins on the Ki67
expression in CAL and to those belong IL-8 and IL-10 due to their strong and moderate inter-correlations
in the epithelium. Our suggestion is indirectly proved also by other authors describing the possible
non-inhibitory functions of IL-10. Furthermore, IL-10 can promote the proliferation, differentiation and
MHC expression of B cells. IL-10 brings into play its biological effect by binding to its receptor, which
is composed of two subunits, IL-10R1 and IL-10R2 [32]. Although the fact that Ki67 shows a high
proliferative activity of human dental stem cells in chronic pulpitis during prolonged inflammation
and transition to the chronic stage [45] is not new itself. Contrary data have also been obtained in a
study where mice were exposed to all-trans retinoic acid to induce cleft palate formation and Ki67
expression was found to be downregulated in mouse embryonic palate mesenchymal cells compared
with untreated control mice [46]. Therefore, we suppose that besides the cytokine stimulating effect on
Ki67 expression the effects of some additional substances may change the cellular proliferation activity
in a different way.
An interesting fact is an absence of Ki67 marked epithelial cells in our control lip. The abnormal
Ki67 immunoreactivity pattern was described in metaplastic columnar epithelia of the oesophagus,
where positive staining for proliferating cells was observed only in the surface epithelium and
superficial third of the foveolar pit [47]. It means that some specific appearance of Ki67 may exist
for some distinct type of epithelium. This is supported by the research on cervical epithelium where
complete absence or just minimal Ki67 expression was observed in the normal cervical epithelium [48].
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Additionally, biomechanical factors, like a masticatory pressure might influence the phenotype of oral
mucosal epithelium and change the proliferation ability in epithelium [49]. As the control lip material
investigated by us enrols only seven cases we can just speculate that probably the upper lip frenulum
tissues belong to some specific region in proliferation ability/intensity aspect what should be more
clarified in future studies with more cases.
Connective tissue of subepithelium in CAL demonstrated significant dominance of IL-4-
and IL-10-containing inflammatory and non-inflammatory cells, while very strong and moderate
inter-correlations were observed between IL-1 and IL-4, IL-1 and IL-10, and IL-4 and IL-10 positive cells.
Therefore, we suppose that from all cytokines in case of cleft triggered inflammation, the IL-1, -4 and
-10 are those, which are the result of the local tissue response. This suggestion of ours is supported also
by the research on the cytokines in periodontal tissue. Hence, IL-10 serves for the control of periodontal
disease progression and the large diversity of its expression pattern in periodontal tissues may be
affected by various micro-environment factors. Significantly negative correlation exists between
the levels of IL-1 and IL-10 in clinically healthy periodontal tissues of the patients and dynamic
relationship between pro- and anti-inflammatory cytokines may be crucial in periodontal homeostasis
and pathogenesis [50]. Despite the separate remarks on the effects of IL-4 on oral tissue cells—still
not well enough examined—and the increased IL-4 level in healthy periodontal tissue [51,52], the
data about the elevated expression of IL-4 and IL-10 secreted by different cells is quite common in
current scientific literature. Additionally, gingival atypical fibroblasts in cases of Chédiak–Higashi
syndrome significantly intensify the expression of IL-4 and IL-10 along with other cytokines. Scientists
indicate the possibly dysregulated immunoinflammatory response in such fibroblasts that may partly
lead to the development of periodontitis [53]. Additionally, in periodontitis granulation tissue Th2
lymphocytes secrete cytokines eliciting humoral type immunity—i.e., IL-4 and IL-10. Simultaneously
IL-4 could be also secreted by Th0 cells. Th2 cells are less effective in promoting microbial killing
compared to Th1 cells as IL-4 and IL-10, products of these cells, downplay these activities by inhibiting
the secretion of IFN-γ. As a result, Th2-dominated response reduces cellular immunity in the presence
of certain bacterial infections, particularly if host cells are invaded and may be associated with failed
control of the infection [54]. Finally, in periapical granulations around the site of inflammation the
significant presence of IL-4 and IL-10 shows the active involvement of the inflammatory cells in the
downregulation of the inflammatory response and modulation of further disease activity [55].
This function could be related to the IL-4 role in common leukocyte survival under pathological
(also physiological) conditions [56], and tissue repair and homeostasis through the so-called “alternative”
macrophage activation, i.e., a pathway of macrophage activation that differs from the classical
pro-inflammatory pathway [57]. On the other hand, hypoxia seems to be a factor, which selectively can
influence the specific cytokines like IL-10, as human gingiva-derived mesenchymal stem cells when
exposed to hypoxia show increase in expression of IL-10, in this manner contributing to the promotion
of immunomodulation and optimizing tissue regeneration [58].
An interesting issue is related to the ontogenetic changes of cytokines, which were not an aim
of our study of the cleft affected tissues and mainly are studied in periodontal tissues. As follows,
in vivo research it has been revealed that during the cellular aging the levels of IL-4 decreased as well
as increased levels of IL-1, IL-6 and slight increase for IL-8 has been shown in the periodontal cells,
suggesting a link between various age-associated diseases and chronic inflammatory state. However,
the age-related decrease on proliferation of periodontal ligament cells has a major role in periodontal
homeostasis [59], and it is probably not a topical question in cleft affected children periodontium
and/or lip.
5. Conclusions
Commonly, the cleft affected epithelium is the main source for the interleukin expression. Rich
similar expression of pro-inflammatory cytokine IL-1 and anti-inflammatory cytokine IL-10 suggests
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the balance between pro-and anti-inflammatory tissue response on the basis of possibly dysregulated
tissue homeostasis (increase of IL-8).
The detected strong and moderate correlations between the appearances of different interleukins
(ILs-1, -4, -8, -10, but not IL-6) in the cleft affected epithelium seem to indicate the common
self-protection compensatory mechanism for intensification of local inflammatory-immune response
without involvement of all pro-inflammatory cytokines (IL-6). The correlations between Ki67 and
cytokines indicate the involvement of IL-8 and IL-10 in stimulation of cellular proliferation.
IL-4 and IL-10 expression from CAL connective tissue cells, mainly macrophages and fibroblasts
simultaneously to IL-1, IL-4 and IL-10 inter-correlations there suggests the intensification of local tissue
immune response regulated probably by main pro-inflammatory cytokine—IL-1.
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